Successfully conducted E&Y cGMP audit in May 2018.    2D barcode printing on all products implemented from May 2018.   Received ISO 9001:2015 Certification in July 2018.   Received ISO 14001:2015 Certification in December 2019.   Received ISO 45001:2018 Certification in December 2020.

Social Responsibility

Our Missions & Our Vissions

Research & Development

About Us

Curexa Health Private Limited was incorporated on 10th June, 2015 as a wholly owned subsidiary of Highnoon Laboratories Ltd, one of Pakistan’s premier pharmaceutical companies. Right from its inception, Highnoon has cultivated a culture of quality and operational excellence. These very same principles became the foundation on which Curexa Health was established.
Curexa specializes in the area of antibiotics, primarily cephalosporins. Our dedicated, state of the art, cGMP manufacturing concern is second to none and encompasses the production of sterile powder for injections, powder for oral suspensions and capsules for the local and export markets. The broad spectral nature of cephalosporins allows Curexa to be present across diverse therapeutic and disease segments ranging from but not limited to respiratory, gastroenterology, urology, gynecology and pediatrics.
We at Curexa believe that our greatest strength is our people and our greatest asset is our continuous commitment to quality. Our objectives are constantly aligned with the needs of patients, healthcare agencies and the medical community at large.

Read More

Excellence in everything we do


Being the subsidiary of a professional organization, we at Curexa Health put great emphasis on creating an inclusive and interactive culture. Inter and intra departmental communication is encouraged and teamwork is the backbone of our success. We have a robust human resource division which holds seminars and conducts internal and external trainings. We take pride in being an equal opportunity employer and do not differentiate across racial, gender and religious lines.


Read More